PCL, Inc.
KOE: 241820.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Soyeon Kim
- Employees
- 31
- Headquarters
- Seoul, South Korea
- IPO year
- 2017
- Market cap
- ₩15.5B
- Website
- http://www.pclchip.com
Loading 241820…
Loading profile data…Frequently asked questions about 241820
What does PCL, Inc. (241820.KQ) do?
PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers multiplex antibody and antigen diagnostic kits for the detection of antibodies to human immunodeficiency virus (HIV) 1 and 2, HBV, hepatitis C virus (HCV), and human T-lymphotropic virus 1 and 2, as well as antigens to HIV p24, HCV core, and...
Where does 241820.KQ trade?
PCL, Inc. (241820.KQ) trades on the KOSDAQ.
What sector is 241820.KQ in?
PCL, Inc. (241820.KQ) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of PCL, Inc.?
Soyeon Kim is the chief executive officer of PCL, Inc. (241820.KQ).
Where is PCL, Inc. headquartered?
PCL, Inc. is headquartered in South Korea.
Does 241820.KQ pay a dividend?
PCL, Inc. (241820.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 241820.KQ go public?
PCL, Inc. (241820.KQ) completed its initial public offering in 2017.